| abstract |
4-yl) furan-3 (2H) -one (prepared by the method described in < RTI ID = 0.0 & Methods for making new crystalline polymorphs and salts thereof, crystalline polymorphs and salts thereof, pharmaceutical compositions comprising the crystalline polymorphs and salts thereof, and crystalline polymorphs and salts thereof The present invention provides a method of treating a disorder or condition selected from the group consisting of CNS disorders, dietary disorders, obesity, obsessive-compulsive gambling, growth disorders, narcolepsy, sleep disorders, diabetes mellitus, metabolic syndrome, asthma, schizophrenia, Huntington ' A method for treating delayed movement disorders or for use in smoking cessation treatment is disclosed. |